Case Study
Top three reasons to go further with MPI Research
Cardiovascular disease, which includes coronary and peripheral artery disease, stroke,myocardial infarct and congestive heart failure, continues to be the leading cause of death worldwide. Despite the clear potential for impacting human health, drug discovery and device development in this area has been hampered by challenges in developing predictive preclinical models for use in evaluating the efficacy and safety of potential therapeutics. Furthermore, the extensive range of techniques, models, and assessments relevant for drug or device development in this space required expertise with these models and can be time consuming.
